Quick Takeaways
- Alejandro Dorenbaum has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $188,271.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Alejandro Dorenbaum
- Location
- San Diego, CA
- Summary
- The estimated net worth of Alejandro Dorenbaum is at least $188,271 dollars as of 13 Dec 2022. Alejandro Dorenbaum is the Chief Medical Officer of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $188.3K.
- Signature
- /s/ Jennifer P. Lam, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Alejandro Dorenbaum and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Reneo Pharmaceuticals, Inc. ($188,271).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Alejandro Dorenbaum
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OKUR | Reneo Pharmaceuticals, Inc. | Chief Medical Officer | $188,271 | 09 Dec 2022 |
Insider Transactions Reported by Alejandro Dorenbaum:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.